"","Term","Overlap","P.value","Adjusted.P.value","Old.P.value","Old.Adjusted.P.value","Z.score","Combined.Score","Genes"
"1","type I interferon signaling pathway (GO:0060337)","9/148",2.50722319083997e-16,1.10819265035127e-13,7.75367933012499e-16,3.42712626391525e-13,-3.28213927326035,117.901616288875,"SP100;RSAD2;STAT2;MX1;ISG15;SAMHD1;XAF1;IFIT1;IFIT3"
"2","cellular response to type I interferon (GO:0071357)","4/23",1.79849726668646e-09,3.97467895937708e-07,6.6745293257811e-09,1.47507098099762e-06,-2.77655793956378,55.909643544706,"SP100;MX1;ISG15;IFIT1"
"3","negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869)","4/44",2.73178788080498e-08,3.0186256082895e-06,7.32539231593073e-08,8.09455850910346e-06,-2.68293118670976,46.7251902599211,"RSAD2;MX1;ISG15;IFIT1"
"4","negative regulation of viral genome replication (GO:0045071)","4/40",1.84233227872793e-08,2.71436955732582e-06,5.12054504329268e-08,7.54426969711788e-06,-2.49401668172103,44.4175602854904,"RSAD2;MX1;ISG15;IFIT1"
"5","negative regulation by host of viral genome replication (GO:0044828)","4/51",5.01338045436727e-08,4.43182832166067e-06,1.27963453867823e-07,1.13119693219156e-05,-2.6224051196754,44.0788808484813,"RSAD2;MX1;ISG15;IFIT1"
"6","response to type I interferon (GO:0034340)","3/35",2.20186307410448e-06,0.000162203913125697,4.69386914625281e-06,0.000345781693773957,-2.71545967327678,35.3721390007812,"SP100;MX1;ISG15"
"7","regulation of type I interferon-mediated signaling pathway (GO:0060338)","3/43",4.13681799598744e-06,0.000261210507746636,8.41191324876799e-06,0.000531152236565065,-2.6859211989198,33.2935609405655,"STAT2;SAMHD1;USP18"
"8","negative regulation of type I interferon-mediated signaling pathway (GO:0060339)","2/43",0.000465750104138902,0.0257326932536744,0.000727491923786076,0.0401939287891807,-2.54884925725256,19.554418039687,"STAT2;USP18"
"9","positive regulation of type I interferon-mediated signaling pathway (GO:0060340)","2/52",0.000681264473621232,0.0334576552600649,0.0010468083144347,0.0514099194422377,-2.51221827404946,18.3179901942441,"STAT2;USP18"
"10","positive regulation of Fas signaling pathway (GO:1902046)","1/7",0.00523898638718187,0.0689542867903496,0.00721937138078378,0.0890405476289651,-2.95632328281185,15.5255078731595,"SP100"
"11","negative regulation of mitochondrial fission (GO:0090258)","1/7",0.00523898638718187,0.0689542867903496,0.00721937138078378,0.0890405476289651,-2.65081442708932,13.9210892453264,"STAT2"
"12","regulation of response to interferon-gamma (GO:0060330)","1/14",0.0104523466401661,0.0689542867903496,0.0134970965862911,0.0890405476289651,-3.03796270260672,13.8559314831287,"SAMHD1"
"13","negative regulation of SREBP signaling pathway by negative regulation of DNA binding (GO:1901294)","1/19",0.0141605504396181,0.0765823236359638,0.0179588844491345,0.0968751914762453,-3.17773164040967,13.5285420365395,"SP100"
"14","negative regulation of DNA replication origin binding (GO:1902596)","1/20",0.01490063310564,0.0765823236359638,0.0188490191560115,0.0968751914762453,-3.21568841730336,13.5263160440491,"SP100"
"15","modulation of complement activation in other organism (GO:0044645)","1/13",0.00970914541854929,0.0689542867903496,0.0126025122256797,0.0890405476289651,-2.91764193144067,13.5223571623974,"SAMHD1"
"16","regulation of interferon-gamma production (GO:0032649)","1/10",0.00747641473212362,0.0689542867903496,0.00991429546701899,0.0890405476289651,-2.75873901945892,13.5067915244371,"ISG15"
"17","modulation by organism of induced systemic resistance in other organism involved in symbiotic interaction (GO:0052298)","1/13",0.00970914541854929,0.0689542867903496,0.0126025122256797,0.0890405476289651,-2.89550697497331,13.419768567169,"SAMHD1"
"18","regulation of antifungal innate immune response (GO:1905034)","1/13",0.00970914541854929,0.0689542867903496,0.0126025122256797,0.0890405476289651,-2.89067252955102,13.397362425765,"SAMHD1"
"19","regulation of defense response to bacterium, incompatible interaction (GO:1902477)","1/14",0.0104523466401661,0.0689542867903496,0.0134970965862911,0.0890405476289651,-2.93550463013915,13.3886275130089,"SAMHD1"
"20","negative regulation of triplex DNA binding (GO:1905497)","1/18",0.0134199488601689,0.0765823236359638,0.0170680095331808,0.0968751914762453,-3.09291086936392,13.3335788362727,"SP100"
"21","regulation of plant-type hypersensitive response (GO:0010363)","1/15",0.0111950272570398,0.0717130731537909,0.014390937936258,0.0921854285192177,-2.95711154459337,13.2841895921696,"SAMHD1"
"22","regulation of innate immunity memory response (GO:1905680)","1/13",0.00970914541854929,0.0689542867903496,0.0126025122256797,0.0890405476289651,-2.86606704879772,13.2833237237182,"SAMHD1"
"23","negative regulation of G-quadruplex DNA binding (GO:1905494)","1/18",0.0134199488601689,0.0765823236359638,0.0170680095331808,0.0968751914762453,-3.08021091508658,13.278829168815,"SP100"
"24","regulation of defense response to fungus, incompatible interaction (GO:2000072)","1/13",0.00970914541854929,0.0689542867903496,0.0126025122256797,0.0890405476289651,-2.8580372153338,13.2461079588625,"SAMHD1"
"25","regulation of natural killer cell mediated immunity (GO:0002715)","1/14",0.0104523466401661,0.0689542867903496,0.0134970965862911,0.0890405476289651,-2.87224262826841,13.1000940288241,"SAMHD1"
"26","positive regulation of T-helper 2 cell cytokine production (GO:2000553)","1/13",0.00970914541854929,0.0689542867903496,0.0126025122256797,0.0890405476289651,-2.82553499640144,13.095470346948,"RSAD2"
"27","regulation of systemic acquired resistance (GO:0010112)","1/13",0.00970914541854929,0.0689542867903496,0.0126025122256797,0.0890405476289651,-2.82236367300213,13.0807722555815,"SAMHD1"
"28","negative regulation of secretion of lysosomal enzymes (GO:0090341)","1/11",0.00822117980349265,0.0689542867903496,0.0108111122279114,0.0890405476289651,-2.72456478967701,13.0807487658319,"RSAD2"
"29","regulation of age-related resistance (GO:1904248)","1/13",0.00970914541854929,0.0689542867903496,0.0126025122256797,0.0890405476289651,-2.81975463553576,13.0686801835249,"SAMHD1"
"30","regulation of melanization defense response (GO:0035007)","1/13",0.00970914541854929,0.0689542867903496,0.0126025122256797,0.0890405476289651,-2.80044117881473,12.9791683565225,"SAMHD1"
"31","negative regulation of atrial cardiac muscle cell action potential (GO:1903948)","1/11",0.00822117980349265,0.0689542867903496,0.0108111122279114,0.0890405476289651,-2.66644293198719,12.8017033119948,"SP100"
"32","negative regulation of matrix metallopeptidase secretion (GO:1904465)","1/10",0.00747641473212362,0.0689542867903496,0.00991429546701899,0.0890405476289651,-2.601485118174,12.7368761224806,"RSAD2"
"33","negative regulation of intraciliary retrograde transport (GO:1905800)","1/7",0.00523898638718187,0.0689542867903496,0.00721937138078378,0.0890405476289651,-2.42101511190598,12.7142689026837,"SP100"
"34","negative regulation of immunoglobulin secretion (GO:0051025)","1/10",0.00747641473212362,0.0689542867903496,0.00991429546701899,0.0890405476289651,-2.59660705117373,12.7129930971019,"RSAD2"
"35","negative regulation of pancreatic trypsinogen secretion (GO:1904243)","1/11",0.00822117980349265,0.0689542867903496,0.0108111122279114,0.0890405476289651,-2.6385761150797,12.6679135661053,"RSAD2"
"36","negative regulation of pancreatic amylase secretion (GO:1902277)","1/11",0.00822117980349265,0.0689542867903496,0.0108111122279114,0.0890405476289651,-2.63568588083913,12.6540374314219,"RSAD2"
"37","negative regulation of telomeric DNA binding (GO:1904743)","1/19",0.0141605504396181,0.0765823236359638,0.0179588844491345,0.0968751914762453,-2.95407264345164,12.5763596358233,"SP100"
"38","negative regulation of prolactin secretion (GO:1902721)","1/10",0.00747641473212362,0.0689542867903496,0.00991429546701899,0.0890405476289651,-2.54815609539469,12.4757771247859,"RSAD2"
"39","negative regulation of tRNA export from nucleus (GO:2000239)","1/7",0.00523898638718187,0.0689542867903496,0.00721937138078378,0.0890405476289651,-2.37490947402076,12.47213927899,"SP100"
"40","regulation of interferon-gamma biosynthetic process (GO:0045072)","1/9",0.00673112769902211,0.0689542867903496,0.00901673344709652,0.0890405476289651,-2.4811984518929,12.408504687168,"ISG15"
"41","negative regulation of Wnt protein secretion (GO:0061358)","1/12",0.00896542325296185,0.0689542867903496,0.0117071842936412,0.0890405476289651,-2.60067112294555,12.260551828028,"RSAD2"
"42","negative regulation of BMP secretion (GO:2001285)","1/11",0.00822117980349265,0.0689542867903496,0.0108111122279114,0.0890405476289651,-2.55199732200022,12.2522451830254,"RSAD2"
"43","negative regulation of ribosomal subunit export from nucleus (GO:2000201)","1/8",0.00598531836349322,0.0689542867903496,0.00811842560621897,0.0890405476289651,-2.37125214505389,12.1371254588621,"SP100"
"44","cohesin unloading (GO:0061774)","1/20",0.01490063310564,0.0765823236359638,0.0188490191560115,0.0968751914762453,-2.87204133568943,12.0808156005008,"SP100"
"45","negative regulation of DNA binding (GO:0043392)","1/23",0.0171177709932522,0.07971975119647,0.0215149876150325,0.100017756029278,-2.94779395009027,11.9905590287274,"SP100"
"46","negative regulation of adiponectin secretion (GO:0070164)","1/18",0.0134199488601689,0.0765823236359638,0.0170680095331808,0.0968751914762453,-2.77307445839071,11.9547599240746,"RSAD2"
"47","regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424)","1/14",0.0104523466401661,0.0689542867903496,0.0134970965862911,0.0890405476289651,-2.59868759236273,11.8524289962279,"SAMHD1"
"48","negative regulation of renin secretion into blood stream (GO:1900134)","1/11",0.00822117980349265,0.0689542867903496,0.0108111122279114,0.0890405476289651,-2.43967296700834,11.7129712874293,"RSAD2"
"49","negative regulation of vesicle transport along microtubule (GO:1901609)","1/6",0.00449213142930971,0.0689542867903496,0.006319570206616,0.0890405476289651,-2.16182427420556,11.6855854282932,"SP100"
"50","negative regulation of protein export from nucleus (GO:0046826)","1/9",0.00673112769902211,0.0689542867903496,0.00901673344709652,0.0890405476289651,-2.33512718029477,11.6780004194005,"SP100"
"51","regulation of Fas signaling pathway (GO:1902044)","1/17",0.0126788280285845,0.0765823236359638,0.016176393849702,0.0968751914762453,-2.64299595778253,11.5441352586705,"SP100"
"52","negative regulation of intraciliary anterograde transport (GO:1905797)","1/6",0.00449213142930971,0.0689542867903496,0.006319570206616,0.0890405476289651,-2.12552022816414,11.4893465218883,"SP100"
"53","negative regulation of transcription from RNA polymerase II promoter (GO:0000122)","2/991",0.168489273287886,0.275541514712418,0.225337623303254,0.327197465330827,-6.37184693538693,11.3475151043124,"SP100;STAT2"
"54","CDP phosphorylation (GO:0061508)","1/8",0.00598531836349322,0.0689542867903496,0.00811842560621897,0.0890405476289651,-2.2141547324729,11.3330308754432,"CMPK2"
"55","negative regulation of anterograde axonal transport of mitochondrion (GO:0061882)","1/6",0.00449213142930971,0.0689542867903496,0.006319570206616,0.0890405476289651,-2.08107393847653,11.2490953038257,"SP100"
"56","negative regulation of interferon-gamma production (GO:0032689)","1/23",0.0171177709932522,0.07971975119647,0.0215149876150325,0.100017756029278,-2.76502390467668,11.247116625588,"ISG15"
"57","purine deoxyribonucleotide catabolic process (GO:0009155)","1/15",0.0111950272570398,0.0717130731537909,0.014390937936258,0.0921854285192177,-2.49549574092453,11.2104795673007,"SAMHD1"
"58","negative regulation of Fas signaling pathway (GO:1902045)","1/16",0.0119371876072553,0.0753748131772404,0.0152840368371803,0.0965077754576242,-2.52311376062038,11.1725918244696,"SP100"
"59","negative regulation of ventricular cardiac muscle cell action potential (GO:1903946)","1/19",0.0141605504396181,0.0765823236359638,0.0179588844491345,0.0968751914762453,-2.59250349108191,11.0370529760831,"SP100"
"60","regulation of TRAIL-activated apoptotic signaling pathway (GO:1903121)","1/17",0.0126788280285845,0.0765823236359638,0.016176393849702,0.0968751914762453,-2.52295142929709,11.0198021548613,"SP100"
"61","negative regulation of ATP-dependent RNA helicase activity (GO:1902281)","1/11",0.00822117980349265,0.0689542867903496,0.0108111122279114,0.0890405476289651,-2.27539553504025,10.9242685105263,"IFIT1"
"62","regulation of mitochondrial fission (GO:0090140)","1/18",0.0134199488601689,0.0765823236359638,0.0170680095331808,0.0968751914762453,-2.52836498890469,10.8998142301351,"STAT2"
"63","negative regulation of nuclear migration along microtubule (GO:1902839)","1/6",0.00449213142930971,0.0689542867903496,0.006319570206616,0.0890405476289651,-2.00790046348229,10.8535613544049,"SP100"
"64","regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041)","1/19",0.0141605504396181,0.0765823236359638,0.0179588844491345,0.0968751914762453,-2.53224120407288,10.7804986237103,"SP100"
"65","establishment of mitochondrion localization involved in mitochondrial fission (GO:0090146)","1/20",0.01490063310564,0.0765823236359638,0.0188490191560115,0.0968751914762453,-2.55606792171169,10.7517203324449,"MX1"
"66","establishment of protein localization to mitochondrial membrane involved in mitochondrial fission (GO:0090152)","1/20",0.01490063310564,0.0765823236359638,0.0188490191560115,0.0968751914762453,-2.54782452397485,10.7170457033778,"MX1"
"67","mitochondrial nucleoid organization involved in mitochondrial fission (GO:0090145)","1/20",0.01490063310564,0.0765823236359638,0.0188490191560115,0.0968751914762453,-2.54334726383305,10.6982127731214,"MX1"
"68","negative regulation of transcription regulatory region DNA binding (GO:2000678)","1/29",0.0215380816061631,0.0848120358422735,0.0268270142594431,0.104906509659084,-2.78154033306922,10.6753645259538,"SP100"
"69","JAK-STAT cascade (GO:0007259)","1/24",0.0178557813765849,0.07971975119647,0.0224021670744311,0.100017756029278,-2.65076738009024,10.6704730651188,"STAT2"
"70","dADP phosphorylation (GO:0006174)","1/8",0.00598531836349322,0.0689542867903496,0.00811842560621897,0.0890405476289651,-2.07036947262475,10.5970738235741,"CMPK2"
"71","negative regulation of helicase activity (GO:0051097)","1/6",0.00449213142930971,0.0689542867903496,0.006319570206616,0.0890405476289651,-1.95140305363352,10.5481686741845,"IFIT1"
"72","dCDP phosphorylation (GO:0061570)","1/8",0.00598531836349322,0.0689542867903496,0.00811842560621897,0.0890405476289651,-2.04712433654094,10.4780948556285,"CMPK2"
"73","mitochondrial membrane fission (GO:0090149)","1/24",0.0178557813765849,0.07971975119647,0.0224021670744311,0.100017756029278,-2.59866292293425,10.4607303276641,"MX1"
"74","dGDP phosphorylation (GO:0006186)","1/8",0.00598531836349322,0.0689542867903496,0.00811842560621897,0.0890405476289651,-2.03445350960184,10.4132399153607,"CMPK2"
"75","deoxyribonucleoside triphosphate biosynthetic process (GO:0009202)","1/8",0.00598531836349322,0.0689542867903496,0.00811842560621897,0.0890405476289651,-2.029870222119,10.3897806070331,"CMPK2"
"76","GDP phosphorylation (GO:0061568)","1/8",0.00598531836349322,0.0689542867903496,0.00811842560621897,0.0890405476289651,-2.00733689271852,10.2744449829789,"CMPK2"
"77","regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531)","1/23",0.0171177709932522,0.07971975119647,0.0215149876150325,0.100017756029278,-2.51786501719742,10.2417637142342,"SAMHD1"
"78","dynamin family protein polymerization involved in mitochondrial fission (GO:0003374)","1/9",0.00673112769902211,0.0689542867903496,0.00901673344709652,0.0890405476289651,-2.04027117448745,10.2034218231948,"MX1"
"79","nucleoside diphosphate phosphorylation (GO:0006165)","1/8",0.00598531836349322,0.0689542867903496,0.00811842560621897,0.0890405476289651,-1.98158999292229,10.1426608731974,"CMPK2"
"80","regulation of establishment of mitochondrion localization involved in mitochondrial fission (GO:0090147)","1/6",0.00449213142930971,0.0689542867903496,0.006319570206616,0.0890405476289651,-1.87289152231517,10.1237802457292,"STAT2"
"81","ribonucleoside triphosphate biosynthetic process (GO:0009201)","1/8",0.00598531836349322,0.0689542867903496,0.00811842560621897,0.0890405476289651,-1.97453980280967,10.1065748575941,"CMPK2"
"82","TDP phosphorylation (GO:0061571)","1/8",0.00598531836349322,0.0689542867903496,0.00811842560621897,0.0890405476289651,-1.96989047589868,10.0827775300363,"CMPK2"
"83","negative regulation of retrograde axon cargo transport (GO:2001018)","1/6",0.00449213142930971,0.0689542867903496,0.006319570206616,0.0890405476289651,-1.86434191141254,10.0775659397037,"SP100"
"84","regulation of histone phosphorylation (GO:0033127)","1/24",0.0178557813765849,0.07971975119647,0.0224021670744311,0.100017756029278,-2.50207057389472,10.0719047873831,"STAT2"
"85","nucleoside triphosphate biosynthetic process (GO:0009142)","1/8",0.00598531836349322,0.0689542867903496,0.00811842560621897,0.0890405476289651,-1.96467272015835,10.056070730354,"CMPK2"
"86","regulation of peptidyl-threonine phosphorylation (GO:0010799)","1/21",0.0156401971948812,0.0785564450015625,0.0197384142138632,0.0991406713923582,-2.39444440878371,9.9558865919108,"STAT2"
"87","positive regulation of mitochondrial fission (GO:0090141)","1/22",0.0163792430449216,0.07971975119647,0.0206270701802231,0.100017756029278,-2.41540269465665,9.93150887516989,"STAT2"
"88","pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148)","1/8",0.00598531836349322,0.0689542867903496,0.00811842560621897,0.0890405476289651,-1.92014966632093,9.82818189475994,"CMPK2"
"89","positive regulation of transcription from RNA polymerase II promoter (GO:0045944)","2/1175",0.219179398340494,0.275541514712418,0.289112044545072,0.346642673647341,-6.47395360643314,9.82658573926582,"SP100;STAT2"
"90","negative regulation of defense response to virus by host (GO:0050689)","1/14",0.0104523466401661,0.0689542867903496,0.0134970965862911,0.0890405476289651,-2.13720473627261,9.74763856244913,"IFIT1"
"91","regulation of peptidyl-serine phosphorylation (GO:0033135)","1/24",0.0178557813765849,0.07971975119647,0.0224021670744311,0.100017756029278,-2.41337740451401,9.71487682557656,"STAT2"
"92","regulation of toll-like receptor signaling pathway (GO:0034121)","1/30",0.0222729936670376,0.0848120358422735,0.0277097775707736,0.104906509659084,-2.54469312921252,9.68098061579637,"SAMHD1"
"93","negative regulation of muscle filament sliding (GO:1904113)","1/7",0.00523898638718187,0.0689542867903496,0.00721937138078378,0.0890405476289651,-1.84223994610855,9.67475747792817,"SP100"
"94","modulation by virus of host protein phosphorylation (GO:0039612)","1/28",0.0208026539976145,0.0848120358422735,0.0259435163152468,0.104906509659084,-2.48763731338548,9.6338100972083,"STAT2"
"95","purine nucleoside triphosphate biosynthetic process (GO:0009145)","1/8",0.00598531836349322,0.0689542867903496,0.00811842560621897,0.0890405476289651,-1.87843374471158,9.61466121318208,"CMPK2"
"96","UDP phosphorylation (GO:0061569)","1/8",0.00598531836349322,0.0689542867903496,0.00811842560621897,0.0890405476289651,-1.86898181648608,9.56628203134758,"CMPK2"
"97","regulation of protein phosphorylation (GO:0001932)","1/31",0.0230073905176292,0.0848120358422735,0.0285918068018595,0.104906509659084,-2.48594358313404,9.3768295114841,"STAT2"
"98","negative regulation of endothelial cell chemotaxis (GO:2001027)","1/21",0.0156401971948812,0.0785564450015625,0.0197384142138632,0.0991406713923582,-2.24507087764552,9.33480475330573,"SP100"
"99","dIDP phosphorylation (GO:0006194)","1/7",0.00523898638718187,0.0689542867903496,0.00721937138078378,0.0890405476289651,-1.75683198458315,9.22622670093146,"CMPK2"
"100","regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393)","1/25",0.0185932745326877,0.0805708563083133,0.0232886091173538,0.100802329440124,-2.29416763575272,9.14215558910504,"STAT2"
"101","IDP phosphorylation (GO:0006192)","1/7",0.00523898638718187,0.0689542867903496,0.00721937138078378,0.0890405476289651,-1.73110937638286,9.09114115110216,"CMPK2"
"102","telomere maintenance via telomere trimming (GO:0090737)","1/32",0.0237412724916266,0.0848120358422735,0.0294731025086736,0.104906509659084,-2.43026255267222,9.09049499372704,"SP100"
"103","telomeric loop disassembly (GO:0090657)","1/32",0.0237412724916266,0.0848120358422735,0.0294731025086736,0.104906509659084,-2.4246969143035,9.06967649916886,"SP100"
"104","negative regulation of axon guidance (GO:1902668)","1/20",0.01490063310564,0.0765823236359638,0.0188490191560115,0.0968751914762453,-2.15209731278369,9.05247792467165,"SP100"
"105","negative regulation of cytokine secretion (GO:0050710)","1/24",0.0178557813765849,0.07971975119647,0.0224021670744311,0.100017756029278,-2.24633825717883,9.0424727753955,"RSAD2"
"106","telomeric loop formation (GO:0031627)","1/31",0.0230073905176292,0.0848120358422735,0.0285918068018595,0.104906509659084,-2.39653707940752,9.03959356278868,"SP100"
"107","regulation of protein autophosphorylation (GO:0031952)","1/23",0.0171177709932522,0.07971975119647,0.0215149876150325,0.100017756029278,-2.21789289509289,9.02158567670313,"STAT2"
"108","mitochondrial DNA inheritance (GO:0033955)","1/31",0.0230073905176292,0.0848120358422735,0.0285918068018595,0.104906509659084,-2.34485733591183,8.84466068207329,"MX1"
"109","positive regulation of bone mineralization involved in bone maturation (GO:1900159)","1/32",0.0237412724916266,0.0848120358422735,0.0294731025086736,0.104906509659084,-2.35129845158982,8.79512659215888,"ISG15"
"110","response to interferon-beta (GO:0035456)","1/38",0.0281337707008429,0.086958927620787,0.0347455037792154,0.107395193499393,-2.45155739956577,8.7539834572467,"XAF1"
"111","ATP generation from ADP (GO:0006757)","1/26",0.0193302507970553,0.0806034986065893,0.0241743143001203,0.100802329440124,-2.20981444651008,8.72011345541837,"CMPK2"
"112","negative regulation of protein autoubiquitination (GO:1905524)","1/36",0.0266716583304887,0.0848120358422735,0.0329909611823817,0.104906509659084,-2.40245209844736,8.70685581325648,"ISG15"
"113","positive regulation of innate immune response (GO:0045089)","1/31",0.0230073905176292,0.0848120358422735,0.0285918068018595,0.104906509659084,-2.28812978771803,8.63068778597597,"SAMHD1"
"114","negative regulation of protein secretion (GO:0050709)","1/27",0.0200667105063091,0.0828923929326042,0.0250592831808837,0.103515917438791,-2.20450629439703,8.61673838890743,"RSAD2"
"115","regulation of blood vessel branching (GO:1905553)","1/26",0.0193302507970553,0.0806034986065893,0.0241743143001203,0.100802329440124,-2.18230817239607,8.61157138692532,"SP100"
"116","negative regulation of innate immune response (GO:0045824)","1/29",0.0215380816061631,0.0848120358422735,0.0268270142594431,0.104906509659084,-2.24264775446063,8.60713109119718,"SAMHD1"
"117","negative regulation of protein monoubiquitination (GO:1902526)","1/34",0.0252074931546333,0.0848120358422735,0.0312334955691383,0.104906509659084,-2.33548645474634,8.59602409837726,"ISG15"
"118","vacuole fusion, non-autophagic (GO:0042144)","1/34",0.0252074931546333,0.0848120358422735,0.0312334955691383,0.104906509659084,-2.33354577905146,8.58888122028157,"MX1"
"119","negative regulation of protein polyubiquitination (GO:1902915)","1/34",0.0252074931546333,0.0848120358422735,0.0312334955691383,0.104906509659084,-2.32792880138298,8.56820729374256,"ISG15"
"120","negative regulation of histone ubiquitination (GO:0033183)","1/35",0.0259398325105781,0.0848120358422735,0.0321125940306974,0.104906509659084,-2.33897303871918,8.5418723656876,"ISG15"
"121","membrane fusion (GO:0061025)","1/33",0.0244746399262893,0.0848120358422735,0.0303536652460137,0.104906509659084,-2.29520486164883,8.5154804177533,"MX1"
"122","multi-organism membrane fusion (GO:0044800)","1/33",0.0244746399262893,0.0848120358422735,0.0303536652460137,0.104906509659084,-2.2899722455587,8.49606679564328,"MX1"
"123","telomere maintenance via telomere lengthening (GO:0010833)","1/35",0.0259398325105781,0.0848120358422735,0.0321125940306974,0.104906509659084,-2.3145954938208,8.45284616758109,"SP100"
"124","regulation of angiogenesis (GO:0045765)","1/24",0.0178557813765849,0.07971975119647,0.0224021670744311,0.100017756029278,-2.0971947165163,8.44210620025612,"SP100"
"125","cellular response to interferon-beta (GO:0035458)","1/36",0.0266716583304887,0.0848120358422735,0.0329909611823817,0.104906509659084,-2.32146425271318,8.41334340737358,"XAF1"
"126","telomere capping (GO:0016233)","1/37",0.0274029709510563,0.0859015117756518,0.0338685975819666,0.106169646320775,-2.338394631837,8.41144831568538,"SP100"
"127","positive regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045870)","1/25",0.0185932745326877,0.0805708563083133,0.0232886091173538,0.100802329440124,-2.10583519763289,8.39165923263366,"IFIT1"
"128","negative regulation of interferon-alpha production (GO:0032687)","1/36",0.0266716583304887,0.0848120358422735,0.0329909611823817,0.104906509659084,-2.30793124127858,8.36429769305675,"ISG15"
"129","plasma membrane fusion (GO:0045026)","1/36",0.0266716583304887,0.0848120358422735,0.0329909611823817,0.104906509659084,-2.28556791397044,8.28324955623753,"MX1"
"130","negative regulation of cell motility (GO:2000146)","1/39",0.0288640579182608,0.087985611033595,0.0356216803264933,0.108584708305587,-2.33114464511674,8.26427638737353,"SP100"
"131","negative regulation of interferon-beta production (GO:0032688)","1/41",0.0303230960900813,0.0911755678354824,0.0373718466808149,0.112369770291974,-2.35878509240084,8.24594850933551,"ISG15"
"132","suppression by virus of host type I interferon production (GO:0039501)","1/33",0.0244746399262893,0.0848120358422735,0.0303536652460137,0.104906509659084,-2.21683286431026,8.22471107520435,"ISG15"
"133","organelle membrane fusion (GO:0090174)","1/35",0.0259398325105781,0.0848120358422735,0.0321125940306974,0.104906509659084,-2.25192377931072,8.22397059808028,"MX1"
"134","negative regulation of blood vessel endothelial cell migration (GO:0043537)","1/30",0.0222729936670376,0.0848120358422735,0.0277097775707736,0.104906509659084,-2.15927840879914,8.21471641500485,"SP100"
"135","regulation of eIF2 alpha phosphorylation by heme (GO:0010999)","1/45",0.0332350366957191,0.0929739634146067,0.0408634478510247,0.114314202216158,-2.40838213989639,8.19849559653581,"STAT2"
"136","regulation of peptidyl-tyrosine phosphorylation (GO:0050730)","1/29",0.0215380816061631,0.0848120358422735,0.0268270142594431,0.104906509659084,-2.13270995769422,8.18519722897389,"STAT2"
"137","regulation of vascular wound healing (GO:0061043)","1/29",0.0215380816061631,0.0848120358422735,0.0268270142594431,0.104906509659084,-2.13152942351583,8.18066641827891,"SP100"
"138","regulation of sprouting angiogenesis (GO:1903670)","1/26",0.0193302507970553,0.0806034986065893,0.0241743143001203,0.100802329440124,-2.07250299469599,8.17827093083987,"SP100"
"139","positive regulation of viral genome replication (GO:0045070)","1/26",0.0193302507970553,0.0806034986065893,0.0241743143001203,0.100802329440124,-2.0723488887847,8.17766281596726,"IFIT1"
"140","positive regulation of bone mineralization (GO:0030501)","1/45",0.0332350366957191,0.0929739634146067,0.0408634478510247,0.114314202216158,-2.39987912834992,8.16955006436043,"ISG15"
"141","negative regulation of type I interferon production (GO:0032480)","1/49",0.0361388140800792,0.0962250350806928,0.0443434363150124,0.118071077417081,-2.45810128795472,8.16184954972388,"ISG15"
"142","regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:0060734)","1/45",0.0332350366957191,0.0929739634146067,0.0408634478510247,0.114314202216158,-2.39750210993736,8.16145833561628,"STAT2"
"143","negative regulation of ubiquitin-protein transferase activity (GO:0051444)","1/41",0.0303230960900813,0.0911755678354824,0.0373718466808149,0.112369770291974,-2.32729062209708,8.13584870359644,"ISG15"
"144","regulation of eIF2 alpha phosphorylation by dsRNA (GO:0060735)","1/47",0.0346879444623774,0.0940617880513548,0.0426048914747055,0.115529828416072,-2.4156586277066,8.11990571111272,"STAT2"
"145","negative regulation of protein ubiquitination (GO:0031397)","1/44",0.0325078176777936,0.0926997123457082,0.0399916376240863,0.114040669869975,-2.36256428069106,8.09479416214178,"ISG15"
"146","JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397)","1/36",0.0266716583304887,0.0848120358422735,0.0329909611823817,0.104906509659084,-2.2068004252011,7.99778406540417,"STAT2"
"147","negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000059)","1/47",0.0346879444623774,0.0940617880513548,0.0426048914747055,0.115529828416072,-2.35797831048809,7.92602122270465,"ISG15"
"148","regulation of respiratory burst involved in inflammatory response (GO:0060264)","1/56",0.0412008456462431,0.105264588298494,0.0504055786410044,0.128781883001872,-2.47458604082836,7.89218859263535,"SAMHD1"
"149","regulation of I-kappaB phosphorylation (GO:1903719)","1/32",0.0237412724916266,0.0848120358422735,0.0294731025086736,0.104906509659084,-2.10475573329068,7.87292362113673,"STAT2"
"150","regulation of protein kinase activity (GO:0045859)","1/44",0.0325078176777936,0.0926997123457082,0.0399916376240863,0.114040669869975,-2.27089153400007,7.78069815179969,"STAT2"
"151","negative regulation of protein phosphorylation (GO:0001933)","1/76",0.055527407959094,0.133386490858258,0.0675322825559655,0.162224287444222,-2.68721265073754,7.76840539256615,"STAT2"
"152","negative regulation of receptor binding (GO:1900121)","1/48",0.0354136338718866,0.0954440620205725,0.0434745259686587,0.117169149256995,-2.31696321721968,7.74018262335671,"IFIT1"
"153","error-free translesion synthesis (GO:0070987)","1/38",0.0281337707008429,0.086958927620787,0.0347455037792154,0.107395193499393,-2.1435879546275,7.65429089985255,"ISG15"
"154","negative regulation of actin binding (GO:1904617)","1/43",0.0317800881265509,0.0926997123457082,0.0391191010528084,0.114040669869975,-2.21096828517863,7.62544244574736,"IFIT1"
"155","negative regulation of apolipoprotein binding (GO:2000657)","1/43",0.0317800881265509,0.0926997123457082,0.0391191010528084,0.114040669869975,-2.20589192458638,7.60793450780473,"IFIT1"
"156","negative regulation of C-C chemokine binding (GO:2001264)","1/44",0.0325078176777936,0.0926997123457082,0.0399916376240863,0.114040669869975,-2.21937408861826,7.60418523338583,"IFIT1"
"157","negative regulation of Ras GTPase binding (GO:1904476)","1/43",0.0317800881265509,0.0926997123457082,0.0391191010528084,0.114040669869975,-2.20444577811929,7.60294687106348,"IFIT1"
"158","negative regulation of heparan sulfate proteoglycan binding (GO:1905859)","1/43",0.0317800881265509,0.0926997123457082,0.0391191010528084,0.114040669869975,-2.20403048053924,7.60151454486696,"IFIT1"
"159","negative regulation of collagen binding (GO:0033342)","1/44",0.0325078176777936,0.0926997123457082,0.0399916376240863,0.114040669869975,-2.21538182229445,7.59050663238614,"IFIT1"
"160","negative regulation of microtubule binding (GO:1904527)","1/46",0.0339617455140867,0.0938193219826644,0.041734532284593,0.115291645436188,-2.24367242176258,7.58926800618827,"IFIT1"
"161","positive regulation by host of viral genome replication (GO:0044829)","1/34",0.0252074931546333,0.0848120358422735,0.0312334955691383,0.104906509659084,-2.06158615262553,7.58790281692068,"IFIT1"
"162","tyrosine phosphorylation of STAT protein (GO:0007260)","1/74",0.0541037947476132,0.131394930101346,0.0658324442969192,0.159878793292518,-2.57741375029761,7.5179317522342,"STAT2"
"163","desensitization of G-protein coupled receptor protein signaling pathway by arrestin (GO:0002032)","1/46",0.0339617455140867,0.0938193219826644,0.041734532284593,0.115291645436188,-2.21574327868357,7.49479710662474,"IFIT1"
"164","negative regulation of endothelial cell migration (GO:0010596)","1/34",0.0252074931546333,0.0848120358422735,0.0312334955691383,0.104906509659084,-2.02568564272684,7.45576689825331,"SP100"
"165","positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043)","1/37",0.0274029709510563,0.0859015117756518,0.0338685975819666,0.106169646320775,-2.07051738955439,7.44786605812676,"SP100"
"166","regulation of eIF2 alpha phosphorylation by amino acid starvation (GO:0060733)","1/80",0.0583686371194935,0.13796223319153,0.0709234561311329,0.167637259946314,-2.62030013593063,7.44421129000071,"STAT2"
"167","regulation of MAPK cascade (GO:0043408)","1/56",0.0412008456462431,0.105264588298494,0.0504055786410044,0.128781883001872,-2.32971364699825,7.43014757441681,"STAT2"
"168","telomere maintenance (GO:0000723)","1/54",0.0397570886531444,0.102763936752572,0.048677145026242,0.125820456734497,-2.28955545337854,7.38374106316591,"SP100"
"169","mitochondrial fission (GO:0000266)","1/79",0.0576590786731495,0.137017810610387,0.0700767242601391,0.166526409263341,-2.55199337823678,7.28136681392419,"MX1"
"170","DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)","1/25",0.0185932745326877,0.0805708563083133,0.0232886091173538,0.100802329440124,-1.82188444594926,7.26012816616765,"SP100"
"171","translesion synthesis (GO:0019985)","1/75",0.0548158515070049,0.132396756098886,0.0666827181635006,0.161058805618947,-2.49475042653412,7.24419607971254,"ISG15"
"172","STAT protein import into nucleus (GO:0007262)","1/67",0.0491053610924787,0.121254578787014,0.0598606166268858,0.147812248877562,-2.40005645122142,7.23325908297509,"STAT2"
"173","positive regulation of toll-like receptor 9 signaling pathway (GO:0034165)","1/6",0.00449213142930971,0.0689542867903496,0.006319570206616,0.0890405476289651,-1.33468551256729,7.21454641947797,"RSAD2"
"174","negative regulation of protein homodimerization activity (GO:0090074)","1/50",0.0368634854145614,0.0969860747216436,0.0452116230636742,0.118949627346095,-2.18405489749554,7.20854695133461,"IFIT1"
"175","positive regulation of interferon-gamma production (GO:0032729)","1/49",0.0361388140800792,0.0962250350806928,0.0443434363150124,0.118071077417081,-2.16547174878074,7.19020599530781,"ISG15"
"176","error-prone translesion synthesis (GO:0042276)","1/39",0.0288640579182608,0.087985611033595,0.0356216803264933,0.108584708305587,-2.00673960052983,7.11420920662587,"ISG15"
"177","response to interferon-gamma (GO:0034341)","1/47",0.0346879444623774,0.0940617880513548,0.0426048914747055,0.115529828416072,-2.10672467007225,7.08146651354557,"SP100"
"178","mitochondrial fusion (GO:0008053)","1/109",0.0787302198413179,0.181243526926367,0.0951733953167629,0.219097087135465,-2.78346347581909,7.0748076364484,"MX1"
"179","negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042)","1/59",0.0433626827930654,0.108899464741676,0.0529928321393582,0.133084271622706,-2.25382865386648,7.07286602856887,"SP100"
"180","regulation of actin phosphorylation (GO:0043538)","1/58",0.042642576415123,0.107702964431339,0.0521311331690297,0.131668347775492,-2.23733053871257,7.05855876677828,"STAT2"
"181","negative regulation of protein binding (GO:0032091)","1/54",0.0397570886531444,0.102763936752572,0.048677145026242,0.125820456734497,-2.17622368702854,7.01824984270875,"IFIT1"
"182","positive regulation of B cell proliferation (GO:0030890)","1/90",0.065436847514509,0.152226771586384,0.0793519898748324,0.184597786971978,-2.57023425703612,7.00818002869882,"TNFSF13B"
"183","negative regulation of angiogenesis (GO:0016525)","1/70",0.0512505579990687,0.125153296329218,0.0624242432966735,0.152439312359832,-2.33892323680667,6.94900823494333,"SP100"
"184","telomere maintenance via recombination (GO:0000722)","1/60",0.0440822836027598,0.110081182782033,0.0538538129724706,0.134482403016,-2.22301850899728,6.93959089874809,"SP100"
"185","negative regulation of insulin secretion (GO:0046676)","1/78",0.0569490212122719,0.136061985815266,0.0692292850671354,0.165401859457697,-2.40594394451826,6.89447002260183,"RSAD2"
"186","negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433)","1/54",0.0397570886531444,0.102763936752572,0.048677145026242,0.125820456734497,-2.11818964707273,6.83109197184313,"SP100"
"187","regulation of inhibitory G-protein coupled receptor phosphorylation (GO:1904323)","1/50",0.0368634854145614,0.0969860747216436,0.0452116230636742,0.118949627346095,-2.06015683755069,6.79961722007378,"STAT2"
"188","negative regulation of CREB transcription factor activity (GO:0032792)","1/57",0.0419219641439958,0.106491426158886,0.0512687155180902,0.130234323327562,-2.13564953560533,6.77416368948066,"SP100"
"189","negative regulation of NF-kappaB transcription factor activity (GO:0032088)","1/115",0.0828913230941905,0.188855488699135,0.100117603460458,0.228102993451147,-2.71927461326669,6.7716053232272,"SP100"
"190","ISG15-protein conjugation (GO:0032020)","1/88",0.0640271793270891,0.149735519907796,0.0776719117328931,0.181645423206025,-2.46143148816225,6.7651154878312,"ISG15"
"191","negative regulation of thyroid hormone receptor activity (GO:1904168)","1/69",0.050535994753213,0.124093942671779,0.0615704139650159,0.15118957206965,-2.25262663077921,6.72424689095997,"SP100"
"192","positive regulation of angiogenesis (GO:0045766)","1/100",0.0724555137596705,0.167671921894107,0.0877103792690845,0.202973757261442,-2.55810169413784,6.71446058242268,"SP100"
"193","regulation of complement activation, alternative pathway (GO:0030451)","1/121",0.0870348795524413,0.196272534500914,0.105037035250284,0.236869232554211,-2.73892591833145,6.68694062125349,"SAMHD1"
"194","regulation of complement activation, lectin pathway (GO:0001868)","1/121",0.0870348795524413,0.196272534500914,0.105037035250284,0.236869232554211,-2.73615831577227,6.68018366815277,"SAMHD1"
"195","negative regulation of androgen receptor activity (GO:2000824)","1/66",0.0483892900300252,0.120157675243096,0.0590046475401623,0.146517158498605,-2.20408809319247,6.67502958952497,"SP100"
"196","apoptotic process (GO:0006915)","1/196",0.137376563287955,0.274816354862339,0.164484939694833,0.327197465330827,-3.29877596831495,6.5481675668288,"MX1"
"197","cellular response to interferon-gamma (GO:0071346)","1/82",0.0597862582845983,0.140561309371236,0.0726148000416081,0.170722029885057,-2.3231324399482,6.54421631741799,"SP100"
"198","apoptotic process in bone marrow (GO:0071839)","1/196",0.137376563287955,0.274816354862339,0.164484939694833,0.327197465330827,-3.29479097804332,6.54025724363575,"MX1"
"199","epithelial cell apoptotic process (GO:1904019)","1/196",0.137376563287955,0.274816354862339,0.164484939694833,0.327197465330827,-3.2933078182797,6.53731312777161,"MX1"
"200","fat cell apoptotic process (GO:1904606)","1/196",0.137376563287955,0.274816354862339,0.164484939694833,0.327197465330827,-3.29038731173229,6.53151583615916,"MX1"
"201","fibroblast apoptotic process (GO:0044346)","1/197",0.138029933890134,0.274816354862339,0.165252523587427,0.327197465330827,-3.29496920070557,6.52497711193164,"MX1"
"202","glial cell apoptotic process (GO:0034349)","1/196",0.137376563287955,0.274816354862339,0.164484939694833,0.327197465330827,-3.2868974572834,6.52458837217414,"MX1"
"203","hepatoblast apoptotic process (GO:1902489)","1/196",0.137376563287955,0.274816354862339,0.164484939694833,0.327197465330827,-3.28426751885376,6.51936786684333,"MX1"
"204","melanocyte apoptotic process (GO:1902362)","1/197",0.138029933890134,0.274816354862339,0.165252523587427,0.327197465330827,-3.29194341427173,6.51898519333581,"MX1"
"205","inflammatory cell apoptotic process (GO:0006925)","1/196",0.137376563287955,0.274816354862339,0.164484939694833,0.327197465330827,-3.28342969108038,6.51770475400847,"MX1"
"206","leukocyte apoptotic process (GO:0071887)","1/196",0.137376563287955,0.274816354862339,0.164484939694833,0.327197465330827,-3.28019857338555,6.51129089010951,"MX1"
"207","myeloid cell apoptotic process (GO:0033028)","1/196",0.137376563287955,0.274816354862339,0.164484939694833,0.327197465330827,-3.27979651256793,6.51049278753114,"MX1"
"208","mesenchymal cell apoptotic process (GO:0097152)","1/197",0.138029933890134,0.274816354862339,0.165252523587427,0.327197465330827,-3.28343428321223,6.502134691245,"MX1"
"209","myofibroblast cell apoptotic process (GO:1904516)","1/196",0.137376563287955,0.274816354862339,0.164484939694833,0.327197465330827,-3.27494279448815,6.50085801402307,"MX1"
"210","anoikis (GO:0043276)","1/203",0.141940468062701,0.275541514712418,0.16984446854245,0.327197465330827,-3.32935653302611,6.50006106460746,"MX1"
"211","retinal cell apoptotic process (GO:1990009)","1/196",0.137376563287955,0.274816354862339,0.164484939694833,0.327197465330827,-3.27410260216778,6.49919020749272,"MX1"
"212","cellular response to exogenous dsRNA (GO:0071360)","1/31",0.0230073905176292,0.0848120358422735,0.0285918068018595,0.104906509659084,-1.71996387710506,6.48760018165532,"IFIT1"
"213","muscle cell apoptotic process (GO:0010657)","1/197",0.138029933890134,0.274816354862339,0.165252523587427,0.327197465330827,-3.26982157262468,6.47517764867351,"MX1"
"214","protein homotetramerization (GO:0051289)","1/173",0.12222085209898,0.26097399337077,0.146650943572244,0.313138729753294,-3.06535143716045,6.4431406823491,"SAMHD1"
"215","negative regulation of cell proliferation involved in kidney development (GO:1901723)","1/283",0.192523540798944,0.275541514712418,0.228898043560007,0.327197465330827,-3.89544968098973,6.41789686896292,"IFIT3"
"216","positive regulation of protein phosphorylation (GO:0001934)","1/151",0.107491856759078,0.234046308805481,0.129266484935163,0.281457075573114,-2.87271540770935,6.40713261492281,"STAT2"
"217","negative regulation of cell proliferation in bone marrow (GO:1903769)","1/282",0.191908804638932,0.275541514712418,0.228184280565054,0.327197465330827,-3.87839725071939,6.4022060687177,"IFIT3"
"218","negative regulation of fibroblast proliferation (GO:0048147)","1/294",0.1992568935291,0.275541514712418,0.23670960124153,0.327197465330827,-3.96858181930002,6.40195889426768,"IFIT3"
"219","neuron apoptotic process (GO:0051402)","1/206",0.143889519824965,0.275541514712418,0.17213174715885,0.327197465330827,-3.30209707726936,6.40180696474304,"MX1"
"220","negative regulation of cell proliferation involved in compound eye morphogenesis (GO:2000496)","1/282",0.191908804638932,0.275541514712418,0.228184280565054,0.327197465330827,-3.87690479225312,6.39974241529791,"IFIT3"
"221","negative regulation of cell proliferation involved in heart morphogenesis (GO:2000137)","1/282",0.191908804638932,0.275541514712418,0.228184280565054,0.327197465330827,-3.87566778146154,6.39770043829427,"IFIT3"
"222","negative regulation of hemocyte proliferation (GO:0035207)","1/283",0.192523540798944,0.275541514712418,0.228898043560007,0.327197465330827,-3.88272020598772,6.39692458990678,"IFIT3"
"223","negative regulation of germ cell proliferation (GO:1905937)","1/282",0.191908804638932,0.275541514712418,0.228184280565054,0.327197465330827,-3.87173566485533,6.3912095558055,"IFIT3"
"224","negative regulation of myoblast proliferation (GO:2000818)","1/285",0.193751703969665,0.275541514712418,0.230323754673371,0.327197465330827,-3.89425459524066,6.39116425197476,"IFIT3"
"225","negative regulation of fat cell proliferation (GO:0070345)","1/287",0.194978123455848,0.275541514712418,0.231747049034011,0.327197465330827,-3.90909984827967,6.39086191503509,"IFIT3"
"226","negative regulation of trophectodermal cell proliferation (GO:1904074)","1/284",0.193137840490268,0.275541514712418,0.229611201445497,0.327197465330827,-3.88539308386238,6.38895056841888,"IFIT3"
"227","negative regulation of hair follicle cell proliferation (GO:0071337)","1/282",0.191908804638932,0.275541514712418,0.228184280565054,0.327197465330827,-3.86934818738642,6.3872684631963,"IFIT3"
"228","negative regulation of leukocyte proliferation (GO:0070664)","1/283",0.192523540798944,0.275541514712418,0.228898043560007,0.327197465330827,-3.8758574499262,6.38561794645181,"IFIT3"
"229","negative regulation of mammary stem cell proliferation (GO:2000102)","1/282",0.191908804638932,0.275541514712418,0.228184280565054,0.327197465330827,-3.86588401957984,6.38155004016723,"IFIT3"
"230","negative regulation of stem cell proliferation (GO:2000647)","1/288",0.195590680075117,0.275541514712418,0.232457791103408,0.327197465330827,-3.9095294385558,6.37930104646578,"IFIT3"
"231","negative regulation of glial cell proliferation (GO:0060253)","1/284",0.193137840490268,0.275541514712418,0.229611201445497,0.327197465330827,-3.87851446314957,6.37763970056986,"IFIT3"
"232","negative regulation of sebum secreting cell proliferation (GO:1904003)","1/282",0.191908804638932,0.275541514712418,0.228184280565054,0.327197465330827,-3.86346412166191,6.37755542998825,"IFIT3"
"233","negative regulation of skeletal muscle cell proliferation (GO:0014859)","1/282",0.191908804638932,0.275541514712418,0.228184280565054,0.327197465330827,-3.86082779327737,6.37320355046393,"IFIT3"
"234","negative regulation of neural precursor cell proliferation (GO:2000178)","1/288",0.195590680075117,0.275541514712418,0.232457791103408,0.327197465330827,-3.90567841708593,6.37301721469555,"IFIT3"
"235","negative regulation of synoviocyte proliferation (GO:1901646)","1/282",0.191908804638932,0.275541514712418,0.228184280565054,0.327197465330827,-3.86046210373065,6.37259989393161,"IFIT3"
"236","negative regulation of cardiac muscle cell proliferation (GO:0060044)","1/287",0.194978123455848,0.275541514712418,0.231747049034011,0.327197465330827,-3.89531209393685,6.36832075785228,"IFIT3"
"237","negative regulation of chorionic trophoblast cell proliferation (GO:1901383)","1/285",0.193751703969665,0.275541514712418,0.230323754673371,0.327197465330827,-3.87832816647196,6.36502615038979,"IFIT3"
"238","negative regulation of osteoblast proliferation (GO:0033689)","1/290",0.19681448837669,0.275541514712418,0.233877467355507,0.327197465330827,-3.90734127169079,6.35135853208332,"IFIT3"
"239","negative regulation of chondrocyte proliferation (GO:1902731)","1/285",0.193751703969665,0.275541514712418,0.230323754673371,0.327197465330827,-3.8647334944222,6.3427148762045,"IFIT3"
"240","negative regulation of growth plate cartilage chondrocyte proliferation (GO:0061914)","1/287",0.194978123455848,0.275541514712418,0.231747049034011,0.327197465330827,-3.87874870985454,6.3412418126669,"IFIT3"
"241","negative regulation of mesenchymal cell proliferation (GO:0072201)","1/284",0.193137840490268,0.275541514712418,0.229611201445497,0.327197465330827,-3.85117537677715,6.33268464257467,"IFIT3"
"242","TNFSF11-mediated signaling pathway (GO:0071847)","1/115",0.0828913230941905,0.188855488699135,0.100117603460458,0.228102993451147,-2.53949242113431,6.32390723369788,"TNFSF13B"
"243","antibacterial humoral response (GO:0019731)","1/156",0.110859469311549,0.240195516841689,0.133245761657017,0.28869915025687,-2.86054267845283,6.29174051384087,"ISG15"
"244","negative regulation of smooth muscle cell proliferation (GO:0048662)","1/303",0.204726982829988,0.275541514712418,0.243046847291138,0.327197465330827,-3.94668441739361,6.25974924267048,"IFIT3"
"245","defense response to Gram-negative bacterium (GO:0050829)","1/162",0.114884949222877,0.247703158812252,0.137998886582863,0.29753906277866,-2.88648620181516,6.24584838741136,"ISG15"
"246","negative regulation of epithelial cell proliferation (GO:0050680)","1/302",0.204120921990533,0.275541514712418,0.24234509838434,0.327197465330827,-3.92313099549939,6.23402269265765,"IFIT3"
"247","apoptotic mitochondrial changes (GO:0008637)","1/268",0.183256504939224,0.275541514712418,0.218127799382084,0.327197465330827,-3.67342152065375,6.23331304970838,"MX1"
"248","interferon-gamma-mediated signaling pathway (GO:0060333)","1/204",0.14259061167261,0.275541514712418,0.170607537590247,0.327197465330827,-3.19377347490793,6.22076046573296,"SP100"
"249","defense response to bacterium (GO:0042742)","1/131",0.0939020006795945,0.206490966668561,0.11318133614975,0.248886321284524,-2.61961930244695,6.19671885521061,"ISG15"
"250","defense response to bacterium, incompatible interaction (GO:0009816)","1/131",0.0939020006795945,0.206490966668561,0.11318133614975,0.248886321284524,-2.61756712885235,6.19186443121245,"ISG15"
"251","induced systemic resistance (GO:0009682)","1/131",0.0939020006795945,0.206490966668561,0.11318133614975,0.248886321284524,-2.61648342958188,6.18930093670145,"ISG15"
"252","male-specific defense response to bacterium (GO:0050831)","1/131",0.0939020006795945,0.206490966668561,0.11318133614975,0.248886321284524,-2.61369041749521,6.18269405659329,"ISG15"
"253","peptidoglycan recognition protein signaling pathway (GO:0061057)","1/131",0.0939020006795945,0.206490966668561,0.11318133614975,0.248886321284524,-2.61135208440261,6.17716272127632,"ISG15"
"254","neutrophil mediated killing of bacterium (GO:0070944)","1/132",0.0945860547311373,0.206965525698825,0.113992018249313,0.249428079535625,-2.61519842586735,6.16727920488624,"ISG15"
"255","regulation of innate immune response (GO:0045088)","1/201",0.140638800266658,0.275541514712418,0.168316399480857,0.327197465330827,-3.12856067071067,6.13686064435424,"SAMHD1"
"256","tumor necrosis factor-mediated signaling pathway (GO:0033209)","1/272",0.185737372365373,0.275541514712418,0.221013266331934,0.327197465330827,-3.59510493700083,6.0520772317924,"TNFSF13B"
"257","defense response to Gram-positive bacterium (GO:0050830)","1/168",0.118893414094488,0.255101403057106,0.142728107402352,0.306241861513784,-2.84020147769534,6.04828819495855,"ISG15"
"258","telomere maintenance in response to DNA damage (GO:0043247)","1/207",0.144538284962837,0.275541514712418,0.172892888672462,0.327197465330827,-3.10004526101762,5.99614120626727,"SP100"
"259","histone deubiquitination (GO:0016578)","1/250",0.172005047927339,0.275541514712418,0.205021554927897,0.327197465330827,-3.37935903077632,5.9484540609552,"USP18"
"260","protein linear deubiquitination (GO:1990108)","1/243",0.167590542521929,0.275541514712418,0.19987052416685,0.327197465330827,-3.32950274870337,5.9472627602989,"USP18"
"261","protein K11-linked deubiquitination (GO:0035871)","1/243",0.167590542521929,0.275541514712418,0.19987052416685,0.327197465330827,-3.32167236495401,5.9332758820212,"USP18"
"262","monoubiquitinated protein deubiquitination (GO:0035520)","1/242",0.166958108650477,0.275541514712418,0.199132170289779,0.327197465330827,-3.31422490695369,5.93250349568743,"USP18"
"263","protein K6-linked deubiquitination (GO:0044313)","1/242",0.166958108650477,0.275541514712418,0.199132170289779,0.327197465330827,-3.31177688305193,5.92812150268381,"USP18"
"264","protein K27-linked deubiquitination (GO:1990167)","1/243",0.167590542521929,0.275541514712418,0.19987052416685,0.327197465330827,-3.31868543031238,5.92794052521198,"USP18"
"265","protein K29-linked deubiquitination (GO:0035523)","1/243",0.167590542521929,0.275541514712418,0.19987052416685,0.327197465330827,-3.31653610059662,5.92410132472381,"USP18"
"266","protein K33-linked deubiquitination (GO:1990168)","1/243",0.167590542521929,0.275541514712418,0.19987052416685,0.327197465330827,-3.31360998106798,5.91887459778641,"USP18"
"267","protein K48-linked deubiquitination (GO:0071108)","1/243",0.167590542521929,0.275541514712418,0.19987052416685,0.327197465330827,-3.31143287046213,5.91498577419667,"USP18"
"268","protein K63-linked deubiquitination (GO:0070536)","1/244",0.168222528230261,0.275541514712418,0.200608253993409,0.327197465330827,-3.31529497371417,5.90940588587092,"USP18"
"269","negative regulation of myeloid cell apoptotic process (GO:0033033)","1/327",0.219143863800733,0.275541514712418,0.259711119908258,0.327197465330827,-3.89271020454042,5.90923861951641,"IFIT3"
"270","protein deubiquitination (GO:0016579)","1/243",0.167590542521929,0.275541514712418,0.19987052416685,0.327197465330827,-3.30600280705282,5.9052864237718,"USP18"
"271","negative regulation of mesenchymal cell apoptotic process (GO:2001054)","1/327",0.219143863800733,0.275541514712418,0.259711119908258,0.327197465330827,-3.88670849753309,5.9001278671184,"IFIT3"
"272","negative regulation of apoptotic process in bone marrow (GO:0071866)","1/325",0.217951838533161,0.275541514712418,0.258335384934586,0.327197465330827,-3.86221053037772,5.88400499736896,"IFIT3"
"273","negative regulation of apoptotic process involved in development (GO:1904746)","1/325",0.217951838533161,0.275541514712418,0.258335384934586,0.327197465330827,-3.85867307673539,5.87861575337365,"IFIT3"
"274","negative regulation of compound eye retinal cell apoptotic process (GO:1901693)","1/325",0.217951838533161,0.275541514712418,0.258335384934586,0.327197465330827,-3.85402362194345,5.87153239657172,"IFIT3"
"275","negative regulation of epithelial cell apoptotic process (GO:1904036)","1/325",0.217951838533161,0.275541514712418,0.258335384934586,0.327197465330827,-3.85122498596746,5.86726872737529,"IFIT3"
"276","negative regulation of fat cell apoptotic process (GO:1904650)","1/325",0.217951838533161,0.275541514712418,0.258335384934586,0.327197465330827,-3.85073510903921,5.86652240910204,"IFIT3"
"277","negative regulation of myofibroblast cell apoptotic process (GO:1904521)","1/325",0.217951838533161,0.275541514712418,0.258335384934586,0.327197465330827,-3.84684904225821,5.8606020595562,"IFIT3"
"278","negative regulation of muscle cell apoptotic process (GO:0010656)","1/326",0.218548063308403,0.275541514712418,0.259023545091484,0.327197465330827,-3.84512445645651,5.84747039963147,"IFIT3"
"279","negative regulation of fibroblast apoptotic process (GO:2000270)","1/326",0.218548063308403,0.275541514712418,0.259023545091484,0.327197465330827,-3.82908723666332,5.82308180854813,"IFIT3"
"280","negative regulation of glial cell apoptotic process (GO:0034351)","1/330",0.220928722471113,0.275541514712418,0.261770336747635,0.327197465330827,-3.84301326364624,5.80262395704329,"IFIT3"
"281","negative regulation of leukocyte apoptotic process (GO:2000107)","1/331",0.221522828680715,0.275541514712418,0.262455574683186,0.327197465330827,-3.84129285937508,5.78971041817831,"IFIT3"
"282","negative regulation of execution phase of apoptosis (GO:1900118)","1/330",0.220928722471113,0.275541514712418,0.261770336747635,0.327197465330827,-3.81817449132308,5.76511951834947,"IFIT3"
"283","canonical Wnt signaling pathway involved in negative regulation of apoptotic process (GO:0044336)","1/371",0.244943283677927,0.293400898064075,0.289391734334545,0.346642673647341,-4.05942643558147,5.71051122767449,"IFIT3"
"284","negative regulation of leucine import by regulation of transcription from RNA polymerase II promoter (GO:1902574)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.58644772468532,5.70969064998353,"STAT2"
"285","carbon catabolite regulation of transcription from RNA polymerase II promoter (GO:0000429)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.5864246658874,5.70965393995373,"STAT2"
"286","negative regulation of anoikis (GO:2000811)","1/336",0.224487022233182,0.275541514712418,0.265873026988025,0.327197465330827,-3.82032990686597,5.70733365521942,"IFIT3"
"287","positive regulation of mating type switching by regulation of transcription from RNA polymerase II promoter (GO:1900374)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.58103842209661,5.70107894090964,"STAT2"
"288","regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903756)","1/306",0.206542581823939,0.275541514712418,0.245148520750736,0.327197465330827,-3.61386555413618,5.69996467661759,"STAT2"
"289","positive regulation of phenotypic switching by regulation of transcription from RNA polymerase II promoter (GO:1900546)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.57509135634418,5.69161110300202,"STAT2"
"290","nitrogen catabolite regulation of transcription from RNA polymerase II promoter (GO:0001079)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.57498865012052,5.69144759280755,"STAT2"
"291","regulation of ergosterol biosynthetic process by regulation of transcription from RNA polymerase II promoter (GO:0035960)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.57480070522211,5.6911483810773,"STAT2"
"292","regulation of conjugation with cellular fusion by regulation of transcription from RNA polymerase II promoter (GO:1900406)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.57364685438976,5.68931142935943,"STAT2"
"293","regulation of fungal-type cell wall biogenesis by regulation of transcription from RNA polymerase II promoter (GO:1900415)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.57220024424828,5.68700839944429,"STAT2"
"294","negative regulation of cell proliferation (GO:0008285)","1/399",0.260944489333824,0.308388941939973,0.307707187993849,0.363653949447276,-4.23250197577792,5.68614453172979,"IFIT3"
"295","regulation of mating-type specific transcription from RNA polymerase II promoter (GO:0001196)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.56462114349368,5.67494233183763,"STAT2"
"296","regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900145)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.56274588150923,5.67195688031545,"STAT2"
"297","regulation of iron ion transport by regulation of transcription from RNA polymerase II promoter (GO:1900393)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.56020688991743,5.66791475906764,"STAT2"
"298","regulation of oligopeptide transport by regulation of transcription from RNA polymerase II promoter (GO:0035950)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.55901971968434,5.66602476225181,"STAT2"
"299","regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.55765693726105,5.66385518760371,"STAT2"
"300","regulation of phenotypic switching by regulation of transcription from RNA polymerase II promoter (GO:1900545)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.55677796318596,5.66245584473204,"STAT2"
"301","regulation of transcription involved in cell fate commitment (GO:0060850)","1/306",0.206542581823939,0.275541514712418,0.245148520750736,0.327197465330827,-3.58698778935158,5.65757175757739,"STAT2"
"302","regulation of pyrimidine nucleotide biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900448)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.55298104783051,5.65641108574823,"STAT2"
"303","positive regulation of neural precursor cell proliferation (GO:2000179)","1/335",0.223895027590502,0.275541514712418,0.265190700001004,0.327197465330827,-3.77899587001949,5.65556194434379,"TNFSF13B"
"304","regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0060962)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.55177221509277,5.65448660182711,"STAT2"
"305","regulation of lipid transport by regulation of transcription from RNA polymerase II promoter (GO:0072367)","1/303",0.204726982829988,0.275541514712418,0.243046847291138,0.327197465330827,-3.56475448200636,5.65397858280799,"STAT2"
"306","regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034395)","1/306",0.206542581823939,0.275541514712418,0.245148520750736,0.327197465330827,-3.58469989349092,5.65396317685013,"STAT2"
"307","regulation of transcription from RNA polymerase II promoter in response to copper ion (GO:0061396)","1/309",0.208354311588464,0.275541514712418,0.247244843963421,0.327197465330827,-3.60426113698455,5.65333847673738,"STAT2"
"308","positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway (GO:0038091)","1/327",0.219143863800733,0.275541514712418,0.259711119908258,0.327197465330827,-3.72344251055804,5.65228571478938,"TNFSF13B"
"309","regulation of cellular response to oxidative stress by regulation of transcription from RNA polymerase II promoter (GO:1900427)","1/303",0.204726982829988,0.275541514712418,0.243046847291138,0.327197465330827,-3.56177103200415,5.64924659845942,"STAT2"
"310","positive regulation of cell proliferation involved in compound eye morphogenesis (GO:2000497)","1/327",0.219143863800733,0.275541514712418,0.259711119908258,0.327197465330827,-3.72013522133545,5.64726516094049,"TNFSF13B"
"311","positive regulation of cell proliferation in bone marrow (GO:0071864)","1/327",0.219143863800733,0.275541514712418,0.259711119908258,0.327197465330827,-3.72005402301119,5.64714189970389,"TNFSF13B"
"312","regulation of snRNA transcription from RNA polymerase II promoter (GO:1905380)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.54561567181379,5.64468527184975,"STAT2"
"313","regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901580)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.54446476521671,5.64285300740851,"STAT2"
"314","positive regulation of cell proliferation involved in kidney development (GO:1901724)","1/330",0.220928722471113,0.275541514712418,0.261770336747635,0.327197465330827,-3.73673605457482,5.64215438872845,"TNFSF13B"
"315","positive regulation of germ cell proliferation (GO:1905938)","1/327",0.219143863800733,0.275541514712418,0.259711119908258,0.327197465330827,-3.71648026202694,5.64171683456535,"TNFSF13B"
"316","regulation of replicative cell aging by regulation of transcription from RNA polymerase II promoter in response to caloric restriction (GO:0061434)","1/303",0.204726982829988,0.275541514712418,0.243046847291138,0.327197465330827,-3.55612576835079,5.64029277009578,"STAT2"
"317","positive regulation of leukocyte proliferation (GO:0070665)","1/327",0.219143863800733,0.275541514712418,0.259711119908258,0.327197465330827,-3.71355042316051,5.6372692604926,"TNFSF13B"
"318","regulation of glucose import by regulation of transcription from RNA polymerase II promoter (GO:1900389)","1/304",0.205332612874209,0.275541514712418,0.24374800035361,0.327197465330827,-3.5608172191756,5.63721560113686,"STAT2"
"319","regulation of androgen receptor activity (GO:2000823)","1/309",0.208354311588464,0.275541514712418,0.247244843963421,0.327197465330827,-3.59386599574075,5.63703353940593,"STAT2"
"320","positive regulation of fibroblast proliferation (GO:0048146)","1/345",0.229796040915494,0.278879312563084,0.271987885982689,0.330915223989933,-3.83322588171113,5.63700069701882,"TNFSF13B"
"321","regulation of termination of RNA polymerase II transcription (GO:1904594)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.54042176575137,5.6364164780019,"STAT2"
"322","negative regulation of apoptotic signaling pathway (GO:2001234)","1/338",0.225669747343654,0.275541514712418,0.267235938878798,0.327197465330827,-3.78585106267852,5.63593076743944,"IFIT3"
"323","regulation of thiamine biosynthetic process by regulation of transcription from RNA polymerase II promoter (GO:1900382)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.53962918799673,5.63515467965925,"STAT2"
"324","regulation of thyroid hormone receptor activity (GO:1904167)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.53881939073648,5.63386546754738,"STAT2"
"325","positive regulation of mammary stem cell proliferation (GO:2000103)","1/327",0.219143863800733,0.275541514712418,0.259711119908258,0.327197465330827,-3.71097168754739,5.63335467058638,"TNFSF13B"
"326","regulation of transcription from RNA polymerase II promoter by pheromones (GO:0046019)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.53624665916182,5.62976963162716,"STAT2"
"327","positive regulation of sebum secreting cell proliferation (GO:1904004)","1/327",0.219143863800733,0.275541514712418,0.259711119908258,0.327197465330827,-3.70840585629351,5.62945966984399,"TNFSF13B"
"328","positive regulation of fat cell proliferation (GO:0070346)","1/328",0.219739240319502,0.275541514712418,0.260398109809587,0.327197465330827,-3.71423434158853,5.62823020842665,"TNFSF13B"
"329","negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154)","1/346",0.230383833285322,0.278879312563084,0.272664424755981,0.330915223989933,-3.83392144376084,5.62822934696187,"IFIT3"
"330","regulation of transcription initiation from RNA polymerase II promoter (GO:0060260)","1/303",0.204726982829988,0.275541514712418,0.243046847291138,0.327197465330827,-3.54723632294609,5.62619341649797,"STAT2"
"331","positive regulation of skeletal muscle cell proliferation (GO:0014858)","1/327",0.219143863800733,0.275541514712418,0.259711119908258,0.327197465330827,-3.70580663687401,5.62551398496962,"TNFSF13B"
"332","regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618)","1/308",0.207750831108251,0.275541514712418,0.246546663258874,0.327197465330827,-3.57896965593174,5.62404962515162,"STAT2"
"333","regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0046021)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.53198712878112,5.6229883810263,"STAT2"
"334","positive regulation of synoviocyte proliferation (GO:1901647)","1/327",0.219143863800733,0.275541514712418,0.259711119908258,0.327197465330827,-3.7028381236056,5.62100770211615,"TNFSF13B"
"335","regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter (GO:1900402)","1/302",0.204120921990533,0.275541514712418,0.24234509838434,0.327197465330827,-3.53698094558707,5.62041377246458,"STAT2"
"336","positive regulation of chorionic trophoblast cell proliferation (GO:1901384)","1/328",0.219739240319502,0.275541514712418,0.260398109809587,0.327197465330827,-3.7087048411818,5.61985128066806,"TNFSF13B"
"337","regulation of transcription from RNA polymerase II promoter involved in mammary gland formation (GO:0060597)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.52952559270748,5.61906957038602,"STAT2"
"338","regulation of transcription from RNA polymerase II promoter involved in lung bud formation (GO:0060500)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.52900790133247,5.61824539620857,"STAT2"
"339","regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407)","1/322",0.216160615761979,0.275541514712418,0.256267387811107,0.327197465330827,-3.66688884383883,5.6166966887232,"STAT2"
"340","regulation of transcription from RNA polymerase II promoter in response to methionine (GO:0061432)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.52801601548318,5.61666629571854,"STAT2"
"341","regulation of cAMP-mediated signaling by regulation of transcription from RNA polymerase II promoter (GO:1900391)","1/305",0.205937812451172,0.275541514712418,0.244448558008959,0.327197465330827,-3.55397660198504,5.61592643265746,"STAT2"
"342","positive regulation of myoblast proliferation (GO:2000288)","1/330",0.220928722471113,0.275541514712418,0.261770336747635,0.327197465330827,-3.71843333626375,5.61451883702335,"TNFSF13B"
"343","positive regulation of hemocyte proliferation (GO:0035208)","1/328",0.219739240319502,0.275541514712418,0.260398109809587,0.327197465330827,-3.70257466793801,5.61056214512611,"TNFSF13B"
"344","regulation of transcription from RNA polymerase II promoter involved in somitogenesis (GO:0090236)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.52328603629501,5.60913608197544,"STAT2"
"345","regulation of transcription elongation from RNA polymerase II promoter (GO:0034243)","1/311",0.209559985627323,0.275541514712418,0.248639426532584,0.327197465330827,-3.58787534634876,5.60693516595963,"STAT2"
"346","positive regulation of hair follicle cell proliferation (GO:0071338)","1/328",0.219739240319502,0.275541514712418,0.260398109809587,0.327197465330827,-3.70003377900313,5.60671190129539,"TNFSF13B"
"347","positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138)","1/329",0.220334193110061,0.275541514712418,0.261084515281637,0.327197465330827,-3.70576454676305,5.60537586495145,"TNFSF13B"
"348","positive regulation of glial cell proliferation (GO:0060252)","1/330",0.220928722471113,0.275541514712418,0.261770336747635,0.327197465330827,-3.71061167339109,5.6027087897362,"TNFSF13B"
"349","regulation of transcription involved in anterior neural plate formation (GO:0090019)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.51900882691422,5.60232668608173,"STAT2"
"350","regulation of transcription from RNA polymerase II promoter involved in spinal cord anterior-posterior patterning (GO:0021909)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.51840608038577,5.60136710253778,"STAT2"
"351","regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter (GO:0072364)","1/303",0.204726982829988,0.275541514712418,0.243046847291138,0.327197465330827,-3.53136520538494,5.60102058643943,"STAT2"
"352","regulation of transcription involved in posterior neural plate formation (GO:0090020)","1/301",0.203514430106387,0.275541514712418,0.241642753173763,0.327197465330827,-3.51488754577602,5.59576553081413,"STAT2"
"353","positive regulation of cardiac muscle cell proliferation (GO:0060045)","1/334",0.223302611196531,0.275541514712418,0.264507791724047,0.327197465330827,-3.73170109228515,5.59466862518192,"TNFSF13B"
"354","positive regulation of osteoblast proliferation (GO:0033690)","1/335",0.223895027590502,0.275541514712418,0.265190700001004,0.327197465330827,-3.73795052407599,5.5941343840884,"TNFSF13B"
"355","positive regulation of secondary heart field cardioblast proliferation (GO:0072513)","1/328",0.219739240319502,0.275541514712418,0.260398109809587,0.327197465330827,-3.6892855392324,5.59042494624581,"TNFSF13B"
"356","positive regulation of chondrocyte proliferation (GO:1902732)","1/330",0.220928722471113,0.275541514712418,0.261770336747635,0.327197465330827,-3.69786543473808,5.58346305085995,"TNFSF13B"
"357","positive regulation of mesenchymal cell proliferation (GO:0002053)","1/329",0.220334193110061,0.275541514712418,0.261084515281637,0.327197465330827,-3.69005559370446,5.58161434820447,"TNFSF13B"
"358","negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000080)","1/413",0.268825872250667,0.316856094759452,0.316701702161373,0.371967356192227,-4.2477567652341,5.58024163386376,"IFIT3"
"359","regulation of BMP signaling pathway (GO:0030510)","1/309",0.208354311588464,0.275541514712418,0.247244843963421,0.327197465330827,-3.54754812262154,5.56438325011959,"STAT2"
"360","positive regulation of growth plate cartilage chondrocyte proliferation (GO:0061913)","1/337",0.225078595390036,0.275541514712418,0.266554773126699,0.327197465330827,-3.72547369319865,5.55581987419082,"TNFSF13B"
"361","regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry (GO:1900094)","1/324",0.217355189205569,0.275541514712418,0.257646638963018,0.327197465330827,-3.63936268344023,5.55447702006046,"STAT2"
"362","positive regulation of stem cell proliferation (GO:2000648)","1/334",0.223302611196531,0.275541514712418,0.264507791724047,0.327197465330827,-3.70364557649849,5.552607026449,"TNFSF13B"
"363","positive regulation of smooth muscle cell proliferation (GO:0048661)","1/347",0.23097120697973,0.278879312563084,0.273340387199865,0.330915223989933,-3.78251035366698,5.543126025121,"TNFSF13B"
"364","regulation of SREBP signaling pathway (GO:2000638)","1/318",0.213766361890013,0.275541514712418,0.25350183586106,0.327197465330827,-3.58997192398288,5.53886582410486,"STAT2"
"365","regulation of transcription involved in anterior/posterior axis specification (GO:0044324)","1/311",0.209559985627323,0.275541514712418,0.248639426532584,0.327197465330827,-3.539725444297,5.53168913509453,"STAT2"
"366","positive regulation of trophectodermal cell proliferation (GO:1904075)","1/335",0.223895027590502,0.275541514712418,0.265190700001004,0.327197465330827,-3.69248811576847,5.52609634563432,"TNFSF13B"
"367","negative regulation of neuron apoptotic process (GO:0043524)","1/399",0.260944489333824,0.308388941939973,0.307707187993849,0.363653949447276,-4.06906752108846,5.4665789092807,"IFIT3"
"368","positive regulation of epithelial cell proliferation (GO:0050679)","1/348",0.231558162241294,0.278879312563084,0.274015773711121,0.330915223989933,-3.70692863345624,5.42295559157501,"TNFSF13B"
"369","regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901213)","1/378",0.248973621282412,0.297422542180612,0.294011772188715,0.351224873803816,-3.86013921166589,5.36716970233053,"STAT2"
"370","regulation of transcription from RNA polymerase II promoter by calcium-mediated signaling (GO:1900621)","1/338",0.225669747343654,0.275541514712418,0.267235938878798,0.327197465330827,-3.59887391319622,5.35758113029606,"STAT2"
"371","positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000081)","1/419",0.272179534434228,0.317404917814955,0.320523597912409,0.371967356192227,-4.0485189081938,5.26831084334261,"TNFSF13B"
"372","positive regulation of cell proliferation (GO:0008284)","1/442",0.28490269890771,0.317404917814955,0.33499338082796,0.371967356192227,-4.18719289407626,5.2574710711847,"TNFSF13B"
"373","negative regulation of apoptotic process (GO:0043066)","1/467",0.298496604591514,0.317404917814955,0.350400627788241,0.371967356192227,-4.33085742887643,5.23599243113669,"IFIT3"
"374","torso signaling pathway (GO:0008293)","1/371",0.244943283677927,0.293400898064075,0.289391734334545,0.346642673647341,-3.71796335244372,5.2301653460487,"STAT2"
"375","regulation of transcription from RNA polymerase II promoter involved in kidney development (GO:0060994)","1/340",0.226850788796449,0.276220519691544,0.268596531028264,0.327954880426776,-3.50064786047869,5.19308086188897,"STAT2"
"376","protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947)","1/329",0.220334193110061,0.275541514712418,0.261084515281637,0.327197465330827,-3.40677332094375,5.15311879899628,"USP18"
"377","BMP signaling pathway (GO:0030509)","1/381",0.250694754623187,0.298671378823312,0.295983346276499,0.352627059445317,-3.65170297904496,5.05220117310415,"STAT2"
"378","nitrogen catabolite activation of transcription (GO:0090294)","1/469",0.299573631161343,0.317404917814955,0.351618959487552,0.371967356192227,-4.15195562935553,5.00474674140891,"SP100"
"379","positive regulation of antisense RNA transcription (GO:0060196)","1/469",0.299573631161343,0.317404917814955,0.351618959487552,0.371967356192227,-4.1494529094034,5.00172997518035,"SP100"
"380","positive regulation of chromatin-mediated maintenance of transcription (GO:1904501)","1/469",0.299573631161343,0.317404917814955,0.351618959487552,0.371967356192227,-4.14502214866224,4.99638915813874,"SP100"
"381","positive regulation of mating-type specific transcription, DNA-templated (GO:0045895)","1/469",0.299573631161343,0.317404917814955,0.351618959487552,0.371967356192227,-4.14362715560163,4.9947076404161,"SP100"
"382","positive regulation of transcription by pheromones (GO:0009371)","1/469",0.299573631161343,0.317404917814955,0.351618959487552,0.371967356192227,-4.13952758312869,4.98976603607186,"SP100"
"383","positive regulation of transcription during mitotic cell cycle (GO:0045897)","1/469",0.299573631161343,0.317404917814955,0.351618959487552,0.371967356192227,-4.13935337964593,4.98955605205698,"SP100"
"384","positive regulation of DNA-templated transcription, termination (GO:0060566)","1/472",0.30118627755916,0.317404917814955,0.353442530099018,0.371967356192227,-4.15448226298273,4.98548815846316,"SP100"
"385","positive regulation of transcription from a mobile element promoter (GO:0061435)","1/469",0.299573631161343,0.317404917814955,0.351618959487552,0.371967356192227,-4.13369351674893,4.98273368136729,"SP100"
"386","positive regulation of transcription from mitochondrial promoter (GO:1903109)","1/469",0.299573631161343,0.317404917814955,0.351618959487552,0.371967356192227,-4.13068690486227,4.9791095262978,"SP100"
"387","positive regulation of transcription from RNA polymerase V promoter (GO:1904281)","1/469",0.299573631161343,0.317404917814955,0.351618959487552,0.371967356192227,-4.12933764788306,4.97748313862104,"SP100"
"388","carbon catabolite activation of transcription (GO:0045991)","1/470",0.300111565483488,0.317404917814955,0.352227339541097,0.371967356192227,-4.12812501775305,4.96861535207301,"SP100"
"389","dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940)","1/387",0.254125982745998,0.301945388101428,0.299911361446727,0.356346295052294,-3.59302168058046,4.922170728309,"STAT2"
"390","positive regulation of DNA-templated transcription, initiation (GO:2000144)","1/493",0.312378143098429,0.317404917814955,0.366076470460676,0.371967356192227,-4.19047110428346,4.87578421812779,"SP100"
"391","positive regulation of transcription from RNA polymerase III promoter (GO:0045945)","1/485",0.308134450085449,0.317404917814955,0.361290470912837,0.371967356192227,-4.13926618505017,4.87282306817973,"SP100"
"392","positive regulation of transcription involved in exit from mitosis (GO:0007072)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.09801738511339,4.85270378360025,"SP100"
"393","positive regulation of transcription from RNA polymerase I promoter (GO:0045943)","1/482",0.306536772795611,0.317404917814955,0.359487198249026,0.371967356192227,-4.09291092099131,4.83952972119833,"SP100"
"394","carbon catabolite repression of transcription from RNA polymerase II promoter (GO:0000437)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.08449204501214,4.83668763166243,"SP100"
"395","negative regulation of cellular hyperosmotic salinity response by negative regulation of transcription from RNA polymerase II promoter (GO:1900464)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.07770832735716,4.82865463198536,"SP100"
"396","negative regulation of cellular response to alkaline pH by negative regulation of transcription from RNA polymerase II promoter (GO:1900463)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.07511189399713,4.8255800422982,"SP100"
"397","negative regulation of filamentous growth of a population of unicellular organisms in response to starvation by negative regulation of transcription from RNA polymerase II promoter (GO:1902352)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.07484100154695,4.82525926259075,"SP100"
"398","positive regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071931)","1/487",0.309197658967121,0.317404917814955,0.362490065954897,0.371967356192227,-4.10752880413932,4.82131270614328,"SP100"
"399","negative regulation of mating type switching by negative regulation of transcription from RNA polymerase II promoter (GO:1900474)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.0677051510312,4.81680928165051,"SP100"
"400","negative regulation of induction of conjugation with cellular fusion by negative regulation of transcription from RNA polymerase II promoter (GO:1902625)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.06577300197675,4.81452131013992,"SP100"
"401","negative regulation of invasive growth in response to glucose limitation by negative regulation of transcription from RNA polymerase II promoter (GO:1900460)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.06527341023331,4.81392971412756,"SP100"
"402","negative regulation of phosphatidylcholine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900473)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.06062597804139,4.80842641590738,"SP100"
"403","negative regulation of oligopeptide transport by negative regulation of transcription from RNA polymerase II promoter (GO:0035952)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.06019378236819,4.80791462755182,"SP100"
"404","negative regulation of phosphatidylserine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900526)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.05776836348577,4.80504254618138,"SP100"
"405","negative regulation of pseudohyphal growth by negative regulation of transcription from RNA polymerase II promoter (GO:1900462)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.05603141056721,4.80298571791353,"SP100"
"406","negative regulation of snRNA transcription from RNA polymerase II promoter (GO:1905381)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.04959268548539,4.79536124426448,"SP100"
"407","negative regulation of ceramide biosynthetic process by negative regulation of transcription from RNA Polymerase II promoter (GO:0061427)","1/484",0.3076022731305,0.317404917814955,0.36068989776865,0.371967356192227,-4.06708654823442,4.79488213443477,"SP100"
"408","positive regulation of transcription by transcription factor localization (GO:0061586)","1/490",0.310789613349204,0.317404917814955,0.36428558655401,0.371967356192227,-4.10129242988645,4.7929306126043,"SP100"
"409","negative regulation of inositol biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900471)","1/482",0.306536772795611,0.317404917814955,0.359487198249026,0.371967356192227,-4.0526242364209,4.79189403815741,"SP100"
"410","positive regulation of DNA-templated transcription, elongation (GO:0032786)","1/488",0.30972869136209,0.317404917814955,0.363089088681963,0.371967356192227,-4.08775963544391,4.79109364684208,"SP100"
"411","negative regulation of transcription initiation from RNA polymerase II promoter (GO:0060633)","1/484",0.3076022731305,0.317404917814955,0.36068989776865,0.371967356192227,-4.06281136957749,4.7898419225975,"SP100"
"412","negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000805)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.04386993810654,4.78858460198892,"SP100"
"413","negative regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0010688)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.04381604113007,4.78852077940423,"SP100"
"414","negative regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903758)","1/482",0.306536772795611,0.317404917814955,0.359487198249026,0.371967356192227,-4.0474108777674,4.78572967136861,"SP100"
"415","negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581)","1/482",0.306536772795611,0.317404917814955,0.359487198249026,0.371967356192227,-4.04668634410678,4.78487297004961,"SP100"
"416","negative regulation of transcription from RNA polymerase II promoter by pheromones (GO:0046020)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.04054776993246,4.7846506269583,"SP100"
"417","negative regulation of transcription from RNA polymerase II promoter in response to copper ion (GO:0061398)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.03545425082778,4.77861909094752,"SP100"
"418","negative regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034396)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.03467631117635,4.77769788678094,"SP100"
"419","negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244)","1/487",0.309197658967121,0.317404917814955,0.362490065954897,0.371967356192227,-4.070273076321,4.77758288160107,"SP100"
"420","negative regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901227)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.03408520621043,4.77699792457115,"SP100"
"421","negative regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle (GO:0010674)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.03282697801261,4.7755079824449,"SP100"
"422","negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0007070)","1/482",0.306536772795611,0.317404917814955,0.359487198249026,0.371967356192227,-4.03786411946121,4.77444141676063,"SP100"
"423","positive regulation of gluconeogenesis by negative regulation of transcription from RNA polymerase II promoter (GO:0035949)","1/484",0.3076022731305,0.317404917814955,0.36068989776865,0.371967356192227,-4.04583494460021,4.76982760623989,"SP100"
"424","regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072362)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.02369386600702,4.76469292652381,"SP100"
"425","regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072365)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.02282393831455,4.76366279389919,"SP100"
"426","regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter (GO:0072368)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.01987584169089,4.76017177902648,"SP100"
"427","negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201)","1/485",0.308134450085449,0.317404917814955,0.361290470912837,0.371967356192227,-4.04311351053836,4.75963030659302,"SP100"
"428","transfer RNA gene-mediated silencing (GO:0061587)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.01800742794533,4.75795928024954,"SP100"
"429","negative regulation of mitochondrial unfolded protein response by negative regulation of transcription from RNA polymerase II promoter (GO:1904490)","1/483",0.307069714110244,0.317404917814955,0.360088807022157,0.371967356192227,-4.02882938696219,4.75676019583061,"SP100"
"430","negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010768)","1/484",0.3076022731305,0.317404917814955,0.36068989776865,0.371967356192227,-4.03275381665925,4.7544056411751,"SP100"
"431","regulation of transport by negative regulation of transcription from RNA polymerase II promoter (GO:1900392)","1/481",0.306003448948912,0.317404917814955,0.358885071056788,0.371967356192227,-4.0144311683271,4.75372442057238,"SP100"
"432","negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000820)","1/484",0.3076022731305,0.317404917814955,0.36068989776865,0.371967356192227,-4.03174009391068,4.75321051512141,"SP100"
"433","negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter (GO:1900387)","1/491",0.311319503438155,0.317404917814955,0.364883062498882,0.371967356192227,-4.06934290930026,4.74866091378724,"SP100"
"434","negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894)","1/488",0.30972869136209,0.317404917814955,0.363089088681963,0.371967356192227,-4.04964581160233,4.74642201358827,"SP100"
"435","negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter (GO:1900477)","1/496",0.31396325508118,0.318283850334591,0.367862728571812,0.372925059698947,-4.07496613130711,4.72076400079014,"SP100"
"436","regulation of reactive oxygen species metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904489)","1/492",0.311849013262092,0.317404917814955,0.365480023679065,0.371967356192227,-4.04660868181528,4.71525468112721,"SP100"
"437","negative regulation of neuron apoptotic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904089)","1/534",0.333748388141749,0.336796318627062,0.390092845859067,0.393655337602072,-4.24927201170217,4.66301469898423,"SP100"
"438","negative regulation of chromatin silencing (GO:0031936)","1/509",0.320792745907291,0.324463143457717,0.375549991398921,0.379846902055659,-4.08090290878248,4.63982343545942,"SP100"
"439","chromatin-mediated maintenance of transcription (GO:0048096)","1/554",0.343946437966519,0.34629686920547,0.40150286636546,0.404246621716477,-4.25977944627677,4.54633198674652,"SP100"
"440","phosphorylation of RNA polymerase II C-terminal domain (GO:0070816)","1/596",0.364889946291567,0.366548536956529,0.424829669359453,0.426760713311087,-4.47957492817554,4.51612596548465,"STAT2"
"441","regulation of transcription from RNA polymerase II promoter (GO:0006357)","1/736",0.430281982465857,0.431257678571221,0.496698952922298,0.497825254402847,-4.73199970565828,3.99056402276668,"STAT2"
"442","positive regulation of transcription, DNA-templated (GO:0045893)","1/1004",0.538297834957643,0.538297834957643,0.61182473419703,0.61182473419703,-5.66130181627023,3.5062892100462,"SP100"
